What follows is the the summary from the latest Bell Potter report. Target price reduced to $0.95 from $1. And perhaps damning with faint praise. No mention of DEP-Gemcetabine!
Starpharma (SPL): Q1FY23 Activity report and updates
SPL remains in a good financial position with a cash balance of $42.3 million as at 30 September 2022 and the company is expecting an additional $7m from the Government’s R&D tax incentive in the next few months.
SPL announced this quarter that it signed a second DEP® Research Agreement with MSD, meaning there are now two active antibody dendrimer conjugate (ADC) programs with MSD.
SPL has continued progress on other partnered DEP® programs, including with AstraZeneca, Genentech, and Chase Sun. AstraZeneca continued recruitment into two clinical trials of their DEP® nanoparticle formulation, AZD0466. The Phase 1/2 Advanced Haematological Malignancies trial continued to expand with 12 out of an expected 30+ sites now open. The Phase 1/2 Study of AZD0466 in Advanced Non- Hodgkin Lymphoma has also opened a number of sites in the US and Korea with ~20 sites planned globally.
SPL continues its three Phase 2 trials using its clinical-stage DEP® conjugated chemotherapy agents, DEP® cabazitaxel, DEP® docetaxel and DEP® irinotecan.
- Forums
- ASX - By Stock
- SPL
- Status quo to win out?
Status quo to win out?, page-4
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
-0.001(1.03%) |
Mkt cap ! $39.58M |
Open | High | Low | Value | Volume |
9.6¢ | 9.7¢ | 9.6¢ | $1.473K | 15.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43942 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 2221 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 43942 | 0.096 |
3 | 43908 | 0.095 |
3 | 40638 | 0.094 |
3 | 83394 | 0.093 |
1 | 8435 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 2221 | 2 |
0.098 | 8824 | 2 |
0.100 | 29410 | 2 |
0.105 | 69848 | 2 |
0.110 | 114099 | 6 |
Last trade - 11.32am 10/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online